Volume 27 - Issue 3 - March 2019
Derm Dx
04/03/2019
Amor Khachemoune, MD, FAAD, FACMS; Adeel Ahmad, MD, MBA, FCAP, FASDP; Suresh K. Menon, MD, DABFM
A 70-year-old man presented to the office with concern for a growth developing in a preexisting psoriatic plaque on the left elbow. The patient related that he had noticed this lesion for about 5 months.
A 70-year-old man presented to the office with concern for a growth developing in a preexisting psoriatic plaque on the left elbow. The patient related that he had noticed this lesion for about 5 months.
A 70-year-old man presented to...
04/03/2019
The Dermatologist
Chief Medical Editor Message
03/01/2019
Steven R. Feldman, MD, PhD
If you’re at all fitness-minded, it’s likely you’ve heard of a juggernaut of a company called Peloton. The New York-based startup has been hailed as much for its business model as for its home fitness equipment, having achieved a net worth of...
If you’re at all fitness-minded, it’s likely you’ve heard of a juggernaut of a company called Peloton. The New York-based startup has been hailed as much for its business model as for its home fitness equipment, having achieved a net worth of...
If you’re at all fitness-minded,...
03/01/2019
The Dermatologist
News
03/01/2019
The American Academy of Dermatology and National Psoriasis Foundation have released 2 joint guidelines for the management and treatment of psoriasis. Based on current available evidence, the new guidelines are the first 2 of a series of 6...
The American Academy of Dermatology and National Psoriasis Foundation have released 2 joint guidelines for the management and treatment of psoriasis. Based on current available evidence, the new guidelines are the first 2 of a series of 6...
The American Academy of...
03/01/2019
The Dermatologist
Spotlight
03/15/2019
Benjamin Barankin, MD, FRCPC
Dr Lockshin is the director of the Clinical Trials Center at. U.S. Dermatology Partners, where he oversees various clinical trials in partnership with both industry and the National Institutes of Health.
Dr Lockshin is the director of the Clinical Trials Center at. U.S. Dermatology Partners, where he oversees various clinical trials in partnership with both industry and the National Institutes of Health.
Dr Lockshin is the director of...
03/15/2019
The Dermatologist
Business Insider
03/01/2019
Nick Hernandez, MBA, FACHE
One of the first, and most complex, steps in selling your practice is determining how much it is worth.
One of the first, and most complex, steps in selling your practice is determining how much it is worth.
One of the first, and most...
03/01/2019
The Dermatologist
Skin Cancer Update
03/01/2019
Jill Waldbieser
In the wake of the FDA’s new proposed rule for sun protection products, stakeholders in skin care will need to take action.
In the wake of the FDA’s new proposed rule for sun protection products, stakeholders in skin care will need to take action.
In the wake of the FDA’s new...
03/01/2019
The Dermatologist
Aesthetics Corner
03/01/2019
C. Helen Malone, MD; Anna Bar, MD
This modern tool has a variety of uses, promotes faster healing, and could be a great addition to your dermatology practice.
This modern tool has a variety of uses, promotes faster healing, and could be a great addition to your dermatology practice.
This modern tool has a variety...
03/01/2019
The Dermatologist
NPF Endorsed Features
03/01/2019
Peter D. Zang; Vipawee S. Chat; Donovan G. Kearns
Dermatologists may soon have 2 more FDA-approved drugs for effectively controlling plaque psoriasis.
Dermatologists may soon have 2 more FDA-approved drugs for effectively controlling plaque psoriasis.
Dermatologists may soon have 2...
03/01/2019
The Dermatologist
NEA Approved Features
03/01/2019
Jill Waldbieser
Certain atopic dermatitis comorbidities can be treated—but first, dermatologists have to be vigilant about identifying them.
Certain atopic dermatitis comorbidities can be treated—but first, dermatologists have to be vigilant about identifying them.
Certain atopic dermatitis...
03/01/2019
The Dermatologist
Cover Story
03/02/2019
Brittany Craiglow, MD
Janus kinase inhibitors offer promising new therapeutic options for patients with this frequently devastating condition.
Janus kinase inhibitors offer promising new therapeutic options for patients with this frequently devastating condition.
Janus kinase inhibitors offer...
03/02/2019
The Dermatologist
